Is gabapentin used for anxiety
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Anxiety: A Comprehensive Review
Introduction to Gabapentin and Its Uses
Gabapentin, originally developed as an anticonvulsant, has found a variety of off-label uses in the medical field. It is commonly prescribed for conditions such as restless legs syndrome, postherpetic neuralgia, and neuropathic pain. However, its application extends into the realm of psychiatric disorders, including anxiety, despite limited conclusive evidence1 4.
Gabapentin's Efficacy in Treating Anxiety Disorders
Generalized Anxiety Disorder (GAD)
Gabapentin has shown promise in treating Generalized Anxiety Disorder (GAD). Although there are no large-scale randomized controlled trials, case reports suggest that gabapentin can be effective in managing GAD symptoms. For instance, a case study highlighted a clear dose-response relationship in a patient with GAD, indicating that gabapentin could be a viable treatment option7.
Anxiety in Cancer Patients
Gabapentin has been studied for its effects on anxiety in breast cancer survivors. A randomized, double-blind controlled trial involving 420 breast cancer patients found that both 300 mg and 900 mg doses of gabapentin significantly reduced anxiety symptoms compared to a placebo over an 8-week period3. Another study corroborated these findings, showing that gabapentin effectively reduced anxiety in breast cancer patients experiencing hot flashes8.
Perioperative Anxiety
The use of gabapentin for perioperative anxiety has yielded mixed results. While one study found that gabapentin did not significantly reduce preoperative anxiety in patients undergoing total hip arthroplasty9, another study in pediatric thoracic surgery patients reported a significant reduction in postoperative anxiety with gabapentin administration10. These mixed results suggest that the effectiveness of gabapentin for perioperative anxiety may depend on the specific surgical context and patient population.
Comparative Analysis with Pregabalin
Gabapentin and pregabalin, both gabapentinoids, share similar mechanisms of action and are used off-label for anxiety disorders. Pregabalin is approved for the treatment of Generalized Anxiety Disorder (GAD) in Europe, but not in the United States. Both drugs are considered when traditional anxiolytics like antidepressants and benzodiazepines fail to provide relief5. However, more robust clinical trials are needed to establish gabapentin's efficacy definitively.
Safety and Tolerability
Gabapentin is generally well-tolerated with a favorable side effect profile, making it an attractive option for patients who may be sensitive to the side effects of traditional anxiolytics. It has minimal drug interactions and does not require therapeutic drug monitoring, which adds to its appeal as a treatment option for anxiety disorders6.
Conclusion
Gabapentin shows potential as an effective treatment for various forms of anxiety, including Generalized Anxiety Disorder (GAD), anxiety in breast cancer survivors, and perioperative anxiety in specific contexts. While the evidence is promising, it is largely based on smaller studies and case reports. More extensive, well-designed clinical trials are necessary to confirm gabapentin's efficacy and safety for anxiety disorders. Until then, gabapentin remains a valuable alternative, particularly for patients who are resistant to or cannot tolerate traditional anxiolytics.
Sources and full results
Most relevant research papers on this topic
Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review
Gabapentin shows potential in treating anxiety disorders and alcohol dependence, but more clinical trials are needed to confirm its effectiveness and safety.
Systematic ReviewBiological rationale and potential clinical use of gabapentin and pregabalin in bipolar disorder, insomnia and anxiety: protocol for a systematic review and meta-analysis
This systematic review aims to assess the efficacy and tolerability of gabapentin and pregabalin in treating bipolar disorder, insomnia, and anxiety, aiming to inform future treatment strategies.
Meta-Analysis
Rigorous JournalA randomized, controlled, double-blinded clinical trial of gabapentin 300 versus 900 mg versus placebo for anxiety symptoms in breast cancer survivors
Gabapentin 300 and 900 mg effectively reduce anxiety symptoms in breast cancer survivors, offering a low-cost alternative for both anxiety and hot flashes treatment.
RCT
Large Human TrialRigorous JournalGabapentin and Anxiety
Gabapentin is an effective and minimally side effects alternative for treating anxiety disorders, both with and without concurrent depression.
Gabapentin and Pregabalin for the Treatment of Anxiety Disorders
Both gabapentin and pregabalin show potential in treating primary anxiety disorders, particularly those not responsive to antidepressants and benzodiazepines.
Very Rigorous JournalGabapentin: A Review of Published Experience in the Treatment of Bipolar Disorder and Other Psychiatric Conditions
Gabapentin shows potential in treating bipolar disorder, anxiety disorders, behavioral dyscontrol, and substance use disorders, but more well-designed studies are needed to confirm its effectiveness as monotherapy and as an adjunctive treatment with other mood stabilizers.
Systematic ReviewTreatment of Generalized Anxiety Disorder with Gabapentin
Gabapentin shows a clear dose-response pattern in reducing generalized anxiety disorder symptoms, offering potential for effective treatment in the absence of controlled studies.
Case ReportEffect of gabapentin on anxiety among 306 breast cancer patients: A URCC CCOP study.
Gabapentin 300mg effectively reduces anxiety in breast cancer patients, while 900mg and placebo increase anxiety in patients experiencing 2 hot flashes a day.
RCTLarge Human TrialGabapentin does not reduce preoperative anxiety when given prior to total hip arthroplasty.
Gabapentin 600 mg prior to total hip arthroplasty does not significantly reduce preoperative anxiety.
RCTPerioperative Gabapentin in Pediatric Thoracic Surgery Patients-Randomized, Placebo-Controlled, Phase 4 Trial.
Perioperative gabapentin reduces postoperative anxiety in pediatric patients undergoing the Ravitch procedure without significantly affecting pain or side effects.
RCTRigorous Journal